All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
The ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
During the virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Maximilian Christopeit, University Hospital Tübingen, Tübingen, DE. We asked, When is it safe to schedule an allo-HSCT after COVID-19 infection?
When is it safe to schedule an allo-HSCT after COVID-19 infection?
Christopeit states that we should schedule allo-HSCT as late as possible. He then provides data on overall survival for patients with cancer following COVID-19 detection, and the relationship between immunocompromised hosts and time of being infectious. He concludes with the UKE Hamburg experience, a study investigating the safety of allo-HSCT transplant following intensive conditioning in patients with previous COVID-19.
Severity of SARS-CoV-2 infection and the safety of COVID-19 vaccination in patients receiving HSCT
The coronavirus pandemic has put a great strain on worldwide healthcare systems. Patients with hematologic malignancies have been at greater risk than...
TKI maintenance therapy post-allogeneic HCT improves outcomes in patients with Ph+ ALL
A recent retrospective study published in Blood by Saini et al. compares the clinical outcomes of patients with Ph+ ALL receiving allo-HCT with and without TKI...
Subscribe to get the best content related to ALL delivered to your inbox